Dewpoint Therapeutics, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Jul 13, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Sep 23, 2025 · D | Jul 13, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $59,124,298 | $82,299,400 | $23,175,102 |
| Reported amount sold | $59,124,298 | $77,164,102 | $18,039,804 |
| Reported investor count | — | 23 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001828893-25-000002 · Later SEC source: 0001828893-26-000001
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $82,299,400
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $77,164,102
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001828893-26-000001D/A · Jul 13, 2026 · BiotechnologyOffering: $82,299,400Sold: $77,164,102
Compared with 0001828893-25-000002:
- Reported offering amount: $59,124,298 → $82,299,400
- Reported amount sold: $59,124,298 → $77,164,102
- Reported investor count: Unavailable → 23
-
0001828893-25-000002D · Sep 23, 2025 · BiotechnologyOffering: $59,124,298Sold: $59,124,298